Skip to content
Search

Latest Stories

Four primary causes of NHS winter crisis identified

An expert reference group proposes ‘doable and fully achievable’ actions to address the NHS winter crisis
Hospital emergency, medical staff pushing patient on gurney. (gettyimages)

An expert reference group has proposed ‘doable and fully achievable’ actions to address NHS winter pressures   

Six major organisations, representing patients, NHS staff and providers, have issued a joint statement calling for urgent and emergency care reform to address the ongoing winter crisis.

They have identified four primary causes of the problem or "diagnoses" and proposed solutions to address these challenges.


The Patients Association, Royal College of Emergency Medicine, Royal College of General Practitioners, College of Paramedics, National Association of Primary Care, and Association of Ambulance Chief Executives have joined forces as an expert reference group to work collaboratively with the government and NHS in England to find solutions.

Their statement highlights the ongoing struggles faced by the NHS during winter months, impacting patients, staff, and the overall quality of care.

They stated that poor standards of care are “normalised and accepted” as an inevitable part of the expected annual winter crisis, leaving clinicians “exhausted and demoralised” while working tirelessly to care for patients despite the overwhelming pressures.

The organisations argue that preparing for winter pressures require not only short-term measures but also mid- and long-term actions.

They stress the importance of early planning, stating that “if we are going to be properly prepared for next winter, the planning needs to begin now.”

According to them, four key factors contributing to the crisis are:

  1. Insufficient capacity in primary care to meet the growing patient demand.
  2. Lack of proactive care for patients who are frequent users of urgent and emergency care to stop them from getting so unwell.
  3. A fragmented and disjointed NHS urgent and emergency system makes it hard to navigate patients to get the right care.
  4. Severe overcrowding in emergency departments (EDs) due to lack of flow into and out of hospital beds.

To increase primary care capacity, propose uplifting funding, improving triage systems to free up GP time, and introducing a national alert system for unsafe workloads.

Additionally, they recommend implementing integrated neighbourhood working by aligning community services to primary care networks and using paramedics for home visits and face-to-face services to support primary care.

To improve care for frequent users of urgent and emergency services, the group suggests providing annual body check-ups for older people, delivering NHS services directly in residential and nursing homes, and creating accessible care plans for patients on palliative care pathways.

They also advocate for identifying high-frequency emergency care users and creating personalised care plans to reduce ED visits, along with increasing support for patients in deprived communities.

The group proposes creating a single, 24/7 service in each ED catchment area that combines urgent community response teams, virtual ward teams, and ED teams into a multi-disciplinary team focused on caring for patients at home.

They also highlight the need to improve hospital flow by addressing bottlenecks caused by delayed discharges, which are primarily due to insufficient bed capacity and a lack of social care funding.

The organisations believe that these actions are all “doable and fully achievable” within the next few years with collaborative efforts, with a step change improvement next winter.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less